BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
4.430
+0.030 (0.68%)
At close: Jun 27, 2025, 4:00 PM
4.250
-0.180 (-4.06%)
After-hours: Jun 27, 2025, 6:50 PM EDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $19.90 million as of June 27, 2025. Its market cap has decreased by -65.07% in one year.
Market Cap
19.90M
Enterprise Value
6.35M
1-Year Change
-65.07%
Ranking
Category
Stock Price
$4.43
Market Cap Chart
Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $19.90M, a decrease of -41.13%. That is a compound annual growth rate of -3.27%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.16B |
| Johnson & Johnson | 367.96B |
| AbbVie | 330.23B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 276.86B |
| Abbott Laboratories | 238.78B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |